Point of Care Diagnostics Quadrant Report

Table of Contents

1 Introduction
   1.1 Market Definition

2 Market Overview
   2.1 Introduction
   2.2 Market Dynamics
          Figure 1 POC Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
          2.2.1 Drivers
                    2.2.1.1 High Prevalence of Infectious Diseases in Developing Countries
                    2.2.1.2 Increasing Incidence of Target Conditions
                    2.2.1.3 Growing Government Support
                    2.2.1.4 Shortage of Skilled Laboratory Technicians
                    2.2.1.5 Rising Number of Clia-Waived POC Tests
                                 Table 1 Recent Waivers for Market Products
          2.2.2 Restraints
                    2.2.2.1 Pricing Pressure Owing to Reimbursement Cuts and Budget Constraints
                    2.2.2.2 Stringent and Time-Consuming Regulatory Policies
          2.2.3 Opportunities
                    2.2.3.1 Emerging Markets
                    2.2.3.2 Healthcare Decentralization—Converting Lab Tests to POC Tests
                    2.2.3.3 Increasing Awareness Through Conferences and Events
                    2.2.3.4 POC Tests With Multiplexing Capabilities
          2.2.4 Challenges
                    2.2.4.1 Lack of Alignment With Definitive Central Lab Methods
                    2.2.4.2 Inadequate Knowledge About the Use of POC Devices in Professional Settings
                    2.2.4.3 Reluctance to Change Existing Diagnostic Practices
                    2.2.4.4 High Cost of Devices
                    2.2.4.5 Product Recalls
          2.2.5 Emerging Applications of Point-Of-Care Testing
                    2.2.5.1 Sepsis Biomarkers
                    2.2.5.2 Stroke Markers
                    2.2.5.3 Thyroid Testing
                    2.2.5.4 DNA Testing
                    2.2.5.5 Endocrine Testing

3 Company Evaluation Quadrant
   3.1 Visionary Leaders
   3.2 Innovators
   3.3 Dynamic Differentiators
   3.4 Emerging Companies
          Figure 2 Point of Care Diagnostics Market (Global) Company Evaluation Quadrant

4 Competitive Landscape
   4.1 Introduction
   4.2 Global Market Share Analysis, 2018
          Figure 3 Roche Diagnostics Held the Leading Position in the Point-Of-Care Diagnostics Market in 2018
   4.3 Competitive Scenario
         4.3.1 Product Launches, Enhancements, and Approvals
         4.3.2 Agreements, Partnerships, and Collaborations
         4.3.3 Acquisitions

5 Company Profiles
   5.1 Abbott Laboratories
         5.1.1 Business Overview*
                   Figure 4 Abbott Laboratories: Company Snapshot
         5.1.2 Products Offered*
         5.1.3 Recent Developments*
         5.1.4 MnM View*
         (*Above sections are present for all of below companies)
   5.2 Becton, Dickinson and Company
          Figure 5 BD: Company Snapshot
   5.3 Chembio Diagnostics
          Figure 6 Chembio Diagnostics: Company Snapshot
   5.4 Danaher Corporation
          Figure 7 Danaher Corporation: Company Snapshot
   5.5 Johnson & Johnson
          Figure 8 Johnson & Johnson: Company Snapshot
   5.6 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd.)
          Figure 9 Roche Diagnostics: Company Snapshot
   5.7 Siemens Healthineers Group
          Figure 10 Siemens Healthineers Group: Company Snapshot
   5.8 EKF Diagnostics
          Figure 11 EKF Diagnostics: Company Snapshot
   5.9 Quidel
          Figure 12 Quidel: Company Snapshot
   5.10 Trinity Biotech
            Figure 13 Trinity Biotech: Company Snapshot
   5.11 AccuBioTech
   5.12 Instrumentation Laboratory (A Werfen Company)
   5.13 Nova Biomedical
   5.14 PTS Diagnostics (A Part of Sinocare, Inc.)
   5.15 Sekisui Diagnostics

6 Appendix
   6.1 Methodology

The report profiles the key market players in the Point of Care Diagnostics Market such as Abbott (US), Roche (Switzerland), Siemens (Germany), Danaher (US), Becton, Dickinson and Company (US). The report identifies, and benchmarks these key market players and evaluates them on the basis of business strategy excellence and strength of product portfolio within the Point of Care Diagnostics ecosystem, combining inputs from various industry experts, buyers, and vendors, and extensive secondary research including annual reports, company press releases, investor presentations, free and paid company databases. They are rated and positioned on 2x2 matrix called as ‘Company Evaluation Quadrant’ and identified as Visionary Leaders, Dyamic Differentiators, Innovators, or Emerging Companies.

The report includes market specific company profiles of all 25 players and assesses the recent developments that shape the competitive landscape of this highly fragmented market.

SAMPLES: